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Summary
Productionofthe eosinophilogenic cytokines interleukin 3 (IL3), granulocyte/macrophage colony-
stimulating factor (GM-CSF), and IL5 by mitogen`-stimulated peripheral blood mononuclear
cells was compared between 11 noneosinophilic individuals and seven patients with helminth-
induced eosinophilia. Both the kinetics and quantities of 11,3 and GM-CSF were similar in the
two groups. In contrast, IL5 production at both the protein and the mRNA levelwas markedly
greater in the eosinophilic patients, an observation suggesting that IL5 may be particularly important
in mediating the selective eosinophilia seen in filarial and other helminth infections.
E
osinophilia is a characteristic feature of the host immune
response to helminth infection. The T cell dependence
of this eosinophilic response has been clearly demonstrated
in a number of animal models (1, 2). More recently, several
cytokines (IL3, granulocyte/macrophage CSF [GM-CSF], and
111,5) have been shown to stimulate eosinophilopoiesis in vitro
(3-5). While the effects of IL3 and GM-CSF on in vitro
bone marrow cell growth and differentiation extend to a broad
range of cell types, 11,5 appears to exert its effects primarily
on the development and maturation of eosinophils (6).
In the present study, we have examined the production
of these eosinophilopoietic cytokines by PBMC from eo-
sinophilic patients with filarial helminth infections and from
normal individuals. While mitogen stimulation of PBMC
from both the normal individuals and the eosinophilic pa-
tients induced similar amounts of IL-3 and GM-CSF, PBMC
from the eosinophilic patients produced strikingly greater
amounts of IL5. This observation suggests that 11,5 may be
a distinctive component of the mechanism(s) involved in
eliciting the eosinophilia characteristically associated with
filarial and similar helminth infections.
Materials and Methods
StudyPopulation.
￿
11 healthy individuals without eosinophilia
and seven patients with Loa loa infection were studied. The diag-
nosis of loiasis was documented either parasitologically (presence
of microfilariae in the blood or adult worms in the subcutaneous
tissue) or by strict clinical criteria (the concurrent findings oflocal-
ized angioedema [Calabar swelling], antifilarial serum antibodies,
and characteristic post-treatment responses) (7). Thesepatients with
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loiasis (age range, 26-34 yr; four male, threefemale) had total white
blood cell counts ranging from 4,700 to 14,700 (median, 12,000)
and eosinophil counts ranging from 987 to 6,600 eosinophils/Pl
(median, 4,440 eosinophils/Al). The normal individuals had levels
of eosinophils that did not exceed 500/Wl.
CellsandCulture Conditions.
￿
PBMC were isolated from whole
blood by density gradient centrifugation on Ficoll/Hypaque (8)
and cryopreserved untilused. Cryopreserved PBMC were thawed,
washed twice with RPMI 1640 medium (Biofluids, Rockville, MD)
containing 25 mM Hepes and 80 ttg/ml gentamicin (C-RPMI),
then resuspended at a final concentration of 5 x 106 cells/ml in
C-RPMI supplemented with 10% FCS. For RNA analysis, 5 x
10' cells were cultured in 25-cm2 tissue culture flasks (Corning,
Coming, NY). For supernatant protein determination, 10' cells
were cultured in each well of 24-well, flat-bottomed tissue culture
plates (Costar, Cambridge, MA). Cultures were incubated in a 5%
C02-humidified atmosphere at 37°C for varying times with or
without the addition of PMA (50 ng/ml; Calbiochem-Behring
Corp., San Diego, CA) and ionomycin (1 hg/ml; Calbiochem-
Behring Corp.).
Northern (RNA) Analysis.
￿
Total cellular RNA was extracted
as described (9), and 15-wg samples were fractionated on a 1.2%
agarose/0.66 M formaldehyde gel and transferred to a nylon mem-
brane (Nytran; Schleicher & Schuell, Inc., Keene, NH) according
to manufacturer's recommendations. Equivalent loading and quality
of RNA were assured by ethidium bromide staining. Hybridiza-
tion was carried out in a solution with a final concentration of
50% formamide, 5x Denhardt's solution, 1% SDS, 100 wg/ml
denatured herring sperm DNA, 5 x SSPE (1 x SSPE is 0.18 M NaCl,
10 mM NaP04, pH 7.7, 1 mM EDTA), and 106 cpm/ml of "p-
labeled IL5 riboprobe (describedbelow) for 18-24 h. After hybrid-
ization, filters were washed twice in Ix SSPE/0.5% SDS at 65°C
for 20 min each, then once in O.1x SSPE/0.5% SDS for 60 min
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399-402at 65°C . Autoradiography was performed by exposing XAR film
(Kodak, Rochester, NY) to washed filters at -70°C . Scanning den-
sitometry was used to quantitate band intensities .
Probes.
￿
An 116-specific riboprobe of high specific activity was
generated by in vitro transcription ofa 565-bp EcoRV/NheI fiag-
ment of the full-length human IL5cDNA (kind gift ofR. Coffinan,
DNAX Research Institute) cloned into the PGEM 32 transcrip-
tion vector (Promega Biotec, Madison, WI), using T7 polymerase
and 32P-CTP as per manufacturer's recommendations (Gemini II
riboprobe kit ; Promega Biotec) . An a-actin probe was generated
by nick translation of a 2-kb fragment of the full-length human
cDNA (kind gift of M . Sneller, NIH) using a commercial nick
translation labeling kit (Bethesda Research Laboratories, Gaithers-
burg, MD) .
Cytokine Measurement.
￿
Cytokines were measured in superna-
tants of mitogen-stimulated PBMC by sandwich ELISA . IL5 was
measured as previously described (10) . GM-CSF ELISA was also
performed as previously described (10), except that a nitroiodophenyl
(NIP)-conjugated mAb (21C11-NIP) was used (0.5 Isg/ml) . For
11,3, plates were coated with a rat IgG1 monoclonal anti-IL3 (6G8)
(10 Ag/ml), and, after incubation with supernatant samples, a rat
polyclonal anti-IL3 (1:200) was added . Next, a cocktail of mouse
anti-rat IgG2a, IgG2b, and IgG2c mAbs (1 hg/ml) was added,
followed by a goat anti-mouse immunoperoxidase conjugate
(1:2,000) . The plates were developed as described for the other
cytokines . Each ofthe ELISAs was highly specific for its respective
cytokine and showed no crossreactivity with any other cytokines.
Statistical Analysis.
￿
Unless otherwise stated, the data were com-
pared using student's t test on logarithmically transformed data.
Results
Kinetics ofIL5mRNA and Protein Production afterMitogen
Stimulation . The kinetics of IL5 production by PMA/
ionomycin-stimulated PBMC were studied in both eosino-
philic patients (n = 3) and normal individuals (n = 3) . Rep-
resentative results show that the kinetics of11,5mRNA were
similar in the mitogen-stimulated PBMC from both the
normal and eosinophilic individuals (Fig. 1A) ; IL5mRNA
was clearly detectable by 3 h, peaked by -6 h, and subse-
quently declined. IL5 protein production induced by PMA/
ionomycin was assessed in parallel (Fig. 1 B). IL5 was de-
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Figure 1 .
￿
Kinetics of IL5 production after mitogen stimulation.
PBMC from a normal individual and an eosinophilic patient were
cultured with medium alone (time = 0 h) or with PMA + iono-
mycin for 3, 6, 12, or 24 h . (A) Northern analysis for 11,5 mRNA .
Detection of HA mRNA by Northern analysis required a threefold
longer exposure for the normal individual than for the eosinophilic
patient (6 vs. 2 d) . (B) Supernatant IL5 concentration from the same
cultures : eosinophilic patient (" ) ; and normal individual (O) .
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tectable by 3 h in the PBMC supernatants of all three eo-
sinophilic patients and by 6 h for the normal individuals .
Thereafter, IL5 continued to accumulate, with the rate of
accumulation being greater in supernatants from the eo-
sinophilic individuals' cells . By 24 h, the levels of IL-5 pro-
tein in the supernatant began to plateau in both groups.
Comparison ofILSmRNA Accumulation afterMitogenStim-
ulation in Normaland Eosinophikc Individuals.
￿
After demonstrat-
ing that peak accumulation of IL5 mRNA in PMA/iono-
mycin-stimulated PBMC occurred at 6 h, we compared the
relative amounts of IL5mRNA induced in three normal and
seven eosinophilic individuals . Strikingly greater amounts of
IMmRNA were induced in each of the seven eosinophilic
individuals (Fig. 2, bottom) . Equivalent loading and RNA
transfer were verified by reprobing the same filter with an
a-actin cDNA probe (Fig . 2, top) .
Comparison ofIL3, GM-CSF,andIL5Protein Production after
Mitogen Stimulation ofPBMC from Normal and Eosinop ilic
Individuals. As both IL-3 and GM-CSF (in addition to 116)
have been implicated in the induction of eosinophilia (3, 4),
the production of all these cytokines after PMA/ionomycin
stimulation was compared directly in normal (n = 11) and
eosinophilic (n = 6) individuals (Fig. 3) . Having determined
that the production of IL3 and GM-CSF after PMA/iono-
mycin stimulation was maximal at 24 h and that the kinetics
of production were similar in eosinophilic and normal indi-
viduals (data not shown), we assessed the levels of these three
cytokines in 24-h PBMC culture supernatants . Neither for
IL3 (Fig . 3 A) nor for GM-CSF (Fig . 3 B) were there
significant differences inPBMC responsesbetween the normal
and eosinophilic individuals. In marked contrast, however,
strikingly greater levels of IL5 were found in thePBMC su-
pernatants from the eosinophilic patients (Fig . 3 C) . 11,5 levels
ranged from 18 to 481 pg/ml in the 11 normal, and from
527 to 1519 pg/ml in the six eosinophilic patients, with the
geometric mean of the supernatant IM concentration N13-
fold higher in the group of eosinophilic patients than in the
normal individuals (880 vs. 68 pg/ml, p < 0.001) .
Discussion
Though eosinophil responses in most individuals are tightly
regulated, the presence of helminth infection appears to over-
come these regulatory mechanisms so that high levels ofcir-
culating eosinophils are consistentlyproduced. While the stim-
Figure 2 .
￿
Maximal 11,5 mRNA accumulation in normal (lanes
1-3) and eosinophilic individuals (lanes 4-10) . Northern analysis of
11,5 (bottom) and a-actin (top) mRNA accumulation in PBMC stimu-
lated for 6 h with PMA + ionomycin .d a
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ulation of eosinophilopoiesis in vitro has been described for
IL3, GM-CSF, and IL5, only IL5 appears to have a restricted
(eosinophil) specificity. In the present investigation, stimu-
lation of PBMC by PMA/ionomycin elicited relativelylittle
IL5 productionin the normal individuals but very high levels
of this cytokine in patients with helminth-induced eosino-
philic. That the levels ofboth IL3 and GM-CSF were similar
in the normal and eosinophilic individuals argues in favor
of a clonal expansion ofIL-5-producing cells. Indeed, as human
IL5 has thus far been shown to be produced only by CD4+ T
cells, our findings suggest that the increased IL5 production
by the eosinophilic patients may be due to increased numbers
of IL5-secreting CD4+ cells in their PBMC.
In murine helminth infections, eosinophilia (mediated by
IL5 [11, 12]) and elevation in IgE (mediated by 114 [11])
have been shown to be regulated by a single Th subset (Th2)
capable ofproducing both 114 and 116, but not 11,2 or IFN--y
(13). While an equivalent T cell subset has not been formally
demonstrated in humans, there is evidence that antigen-s
IL4/IL5-secreting, UN-y/IL2-nonsecreting T cell clones
can be established from patients with filarial infections (un-
published data), and such cells may well play a role in medi-
IL-5
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Figure 3.
￿
IL3, GM-CSF, and IL5 levels after
mitogen stimulation. PBMC from six eosino-
philic patients (Pt) and 11 normal individuals
(NI) were stimulated with PMA + ionomycin
for 24 h, and cell-free supernatants were assayed
for 11,3 (A), GM-CSF (B), and IL5 (C) protein
by ELISA. Each data point represents a single
"T ￿patient, and the geometric mean for the group
NJ
￿
Pt
￿
is indicated by a horizontal line.
N
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ating the eosinophilia associated with helminth infections.
Further testing of this hypothesis will require additional cell
fractionation studies, and ultimately, single cell analysis by
in situ hybridization and/or Elispot .
It is not yet clear how ubiquitous is the involvement of
116 in eosinophilic conditions not caused by parasites, but
observations of another eosinophilic state (the idiopathic
hypereosinophilic syndrome) have also implicated either
undefined soluble T cell-derived factors (14), or IL5 directly
(15). In addition, T cells from patients with reactive eo-
sinophilic have been shown to produce IL5 upon IL2 stimu-
lation in vitro (16), and 11,5 has been found to be elevated
in the serum of patients undergoingIL2/lymphokine-activated
killer therapy who subsequently developed eosinophilia (J. S.
Abrams, manuscript submitted for publication). These ob-
servations, taken together with the findings from the present
study, suggest that IL5 may be the common denominator
in a variety ofeosinophilic states, and that its enhanced produc-
tion may be responsible for the abnormally elevated eosino-
phil levels seen not only in parasitic infections but in other
disorders as well.
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